Representative Bureir Alameri of Sheikh Hamad's office and representative Ruyu Wang of XtalPi officially signed the cooperation agreement under the witness of several Sheikhs.
XtalPi, a global leader in digitalization and robotic automation R&D platforms(Stock Code:2228.HK）Commercial Cooperation Agreement Officially Signed with Sheikh Hamad Rakadh Salem Rakadh Office of the UAE Royal Family in Abu Dhabi Recently; Both Parties to Jointly Build the First Automatic Traditional Medicine Modernization R&D Laboratory in the Middle East Region in the UAE; Initial Investment of 30 Million USD (Paid According to Construction Progress)，Pioneering a New Paradigm for Traditional Medicine R&D in the Middle East. This collaboration marks the first large-scale deployment of XtalPi's automated laboratories to the Arab world, aligning with the core objectives of the UAE's "2031 National Investment Strategy" to promote technological and emerging industry development, and will set a new benchmark for scientific and technological cooperation between China and the Middle East. On the signing day, Sheikh Hamad (Sheikh Hamad）, Sheikh Salim (Sheikh Salim）, Sheikh Abdullah (Sheikh Abdullah）, and the CEO of Sheikh Hamad's OfficeBrer Alameri (Bureir Alameri, Wang Ruyu, the signatory representative of XtalPi, Jeson Zheng, Chairman of the UAE 2031 Vision Global Strategic Partner Center, and others jointly attended and witnessed the completion of the signing ceremony.
From the right: Sheikh Salim,Axel Leven, Strategic Investment and Financing Director of XtalPi, Sheikh Hamad, Jeson Zheng, Chairman of the 2031 Vision Global Strategic Partners Center, Wang Ruyu, Senior Director of XtalPi, Bureir Alameri, CEO of Sheikh Hamad's Office, Sheikh Abdullah
The laboratory project is scheduled to officially launch the first phase of construction in April 2025. It will serve the Arab world's drug research and development heritage and innovation, establishing a globally leading local pharmaceutical ingredient database and pharmaceutical R&D innovation platform. Meanwhile, the project has also received direct support from the UAE National Strategic Emerging Industries Transformation Agency. In the future, XtalPi will deepen multi-dimensional cooperation with the UAE Ministry of Health and the Drug Regulatory Authority.To lay a institutional foundation for the management and approval of innovative R&D in related fields.This collaboration represents an innovative application exploration of XtalPi's high-precision, high-flexibility scientist robot cluster and high-throughput data mining and analysis platform in the field of drug discovery. XtalPi has taken the lead in seizing overseas commercial opportunities, building platforms for niche R&D scenarios, and will deepen cooperation with strategic partners in the future. This effort aims to provide a "Chinese solution" for the deep integration of traditional heritage and modern technology, as well as specialized domain knowledge and general technology platforms.XtalPiWen Shuhao, Chairman of the Board of XtalPi, said:"This collaboration is a global validation of China's independently developed intelligent R&D system and quality standards. We are building a pharmaceutical innovation corridor spanning across Europe and Asia, making automation and data-driven R&D paradigms the universal language for the upgrading of traditional medicine."CEO Bureir Alameri of Sheikh Hamad's Office stated：“"This collaboration marks a strategic milestone for the UAE in implementing its 'Vision 2031' and embracing a technology-driven future. It represents the resonance between 'Made in China' and the rich cultural heritage of the Middle East. We look forward to the deep integration of the UAE's millennium-old medical wisdom with XtalPi's cutting-edge robotic experimental technologies, establishing a 'gold standard' for the modernization of global traditional medicine, and providing smarter and more diverse health solutions for 1.8 billion Muslims and all humanity."In the future, the project will also rely on the UAE "Vision 2031" to address public health priorities for the population of the UAE and the Arab region, further strengthening cooperation with local ministries of health and drug regulatory authorities. XtalPi plans to use this as an opportunity to further expand into the Middle East and North African regional markets, empowering innovation at the source of global pharmaceutical R&D and promoting digital and automated upgrades, creating more value for the upstream and downstream sectors of the broader health industry.The Middle East has a long history of traditional medicine and a unique pharmaceutical system, and is currently actively embracing modern technologies such as digitalization and robotic experimentation. XtalPi's technical outputIt can not only meet the demand for efficient and standardized technologies in the R&D of local traditional medicine, but also tap into high-end consumer goods, health products, cosmetics, and fragrance fields through a natural product ingredient database, unlocking a vast blue ocean market in the halal industry.AndBy promoting international cooperation and participating in standard co-construction, achieve a leapfrog development from being a leader in R&D new infrastructure to a global rule maker.● CloseInOffice of Sheikh Hamad ●
Sheikh Hamad Rakadh Salem Rakadh Office, inherited from Sheikh Rakadh Groups, is a diversified business group with over 30 years of history. Its operations span across oil and gas, aviation services, trade, real estate, investment management, healthcare, and commercial services. We are committed to becoming the preferred choice for customers, partners, and employees among companies operating in the United Arab Emirates, fostering long-term partnerships through trust and shared vision. The group attracts top industry talent, develops high-quality business opportunities, and drives sustainable growth with strict professional standards and excellent corporate governance.
